NFE2L2 and lung carcinoma: In humans, an NRF2 single nucleotide polymorphism (SNP) homozygous allele (-617A7A) exhibits a decreased expression of NRF2 and its target cytoprotective products, and is consequently associated with an increased risk of lung cancer in smokers [51].